NCT02641808

Brief Summary

Follicular aspiration as well as follicular flushing are standardized techniques and have been practiced in polyfollicular IVF (in vitro fertilization) therapy for years. Monofollicular IVF therapy is a standard technique as well. IVF can be done in natural cycles or with a minimal stimulation with clomifen citrate to achieve a monofollicular response. Our study aims to compare follicular aspiration and follicular flushing in monofollicular stimulation. First the investigators want to answer the question whether flushing is beneficial for the oocyte yield. In case of a positive result the investigators want to establish a recommendation about the optimal number of flushings taking into account the duration of the procedure and the pain during manipulation.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
164

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Aug 2016

Typical duration for phase_3

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 12, 2015

Completed
17 days until next milestone

First Posted

Study publicly available on registry

December 29, 2015

Completed
7 months until next milestone

Study Start

First participant enrolled

August 1, 2016

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 17, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 17, 2020

Completed
Last Updated

July 20, 2020

Status Verified

July 1, 2020

Enrollment Period

4 years

First QC Date

December 12, 2015

Last Update Submit

July 17, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Proportion of mature oocytes retrieved

    day of intervention

Secondary Outcomes (7)

  • Number of flushings necessary to retrieve the oocyte (intervention arm only)

    day of intervention

  • Fertilisation rate

    one day after intervention

  • Embryo quality (BLEFCO and ASEBIR score) on day 2 after fertilisation

    two days after intervention

  • Transfer rate

    2-3 days after intervention

  • Pregnancy rate

    up to 9 months after the intervention

  • +2 more secondary outcomes

Study Arms (2)

follicular flushing group

EXPERIMENTAL

Monofollicular IVF therapy with follicular flushing up to five times after aspiration of the follicule at the time to the oocyte pick-up

Other: follicular flushing

aspiration group

ACTIVE COMPARATOR

Monofollicular IVF therapy with aspiration only at the time of the oozyte pick-up

Other: no follicular flushing

Interventions

Depending on randomisation the follicle is not flushed (group A) or flushed adapted to follicule size (16mm 2ml, 18mm 3ml, and 20mm 4ml etc.) up to five times with (e.g.flushing media with heparin (SynVitro® Flush, Origio, Berlin, Germany). The flushings are collected each in a separate collecting tube (group B). The analysis of the collected oocytes is performed in the IVF lab.

follicular flushing group
aspiration group

Eligibility Criteria

Age18 Years - 42 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Indication for in vitro Fertilisation
  • Desire of natural cycle IVF and ICSI fertilisation
  • Regular menstrual cycle, both ovaries can be reached for follicule aspiration
  • years
  • size of the follicle ≥16mm
  • max. 2 previous embryo transfers

You may not qualify if:

  • \<18 and \>42 years
  • Preterm ovulation
  • \>= 3 previous embryo transfers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Kohl Schwartz AS, Calzaferri I, Roumet M, Limacher A, Fink A, Wueest A, Weidlinger S, Mitter VR, Leeners B, Von Wolff M. Follicular flushing leads to higher oocyte yield in monofollicular IVF: a randomized controlled trial. Hum Reprod. 2020 Oct 1;35(10):2253-2261. doi: 10.1093/humrep/deaa165.

MeSH Terms

Conditions

Infertility

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital Diseases

Study Officials

  • Alexandra S Kohl Schwartz, MD

    Reproductive Endocrinologist

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. med.

Study Record Dates

First Submitted

December 12, 2015

First Posted

December 29, 2015

Study Start

August 1, 2016

Primary Completion

July 17, 2020

Study Completion

July 17, 2020

Last Updated

July 20, 2020

Record last verified: 2020-07

Data Sharing

IPD Sharing
Will not share